IP Library Granted Patent US 12,324,892
Granted Patent B2
US 12,324,892 · App. 17/603,631 · Granted Jun 10, 2025

Wound oxygen treatment system

Inventors: Mark Q Niederauer (San Antonio, TX); James P. Daley (San Antonio, TX); Joseph J. Moffett (Crownsville, MD)
Assignee: Electrochemical Oxygen Concepts, Inc.
A61M35/30A61M1/74A61M1/75A61M1/85A61M1/91A61M1/94A61M1/966A61M1/96A61M2202/0208A61M2205/13A61M2205/15A61M2205/18A61M2205/3334
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,324,892
App. No.
17/603,631
Granted
Jun 10, 2025
Kind
B2
Abstract

A wound treatment system includes a processor coupled to sensor system(s), a power delivery system, an oxygen concentrator coupled to the power delivery system and including an oxygen outlet coupled to a restricted airflow enclosure provided by a dressing and located adjacent a wound site, and a negative pressure system that includes a negative pressure outlet coupled to the restricted airflow enclosure. The processor receives first sensor information from the sensor system(s), and uses the first sensor information to control the power provided from the power delivery system to the oxygen concentrator in order to control an oxygen flow created by the oxygen concentrator and provided through the oxygen outlet to the restricted airflow enclosure. When the processor receives second sensor information from the sensor system(s), it activates the negative pressure system to create a fluid flow from the restricted airflow enclosure and through the negative pressure outlet.

Claims (20)

1. A wound treatment system, comprising:

a housing;

a processor that is located in the housing;

at least one sensor system that is coupled to the processor, wherein the at least one sensor system comprises a humidity sensor;

a power delivery system that is located in the housing and that is coupled to the processor;

an oxygen concentrator that is located in the housing and that is coupled to the power delivery system, wherein the oxygen concentrator includes an oxygen outlet that is coupled to a restricted airflow enclosure that is provided by a dressing and that is located adjacent a wound site; and

a negative pressure system that is coupled to the processor, wherein the negative pressure system includes a negative pressure outlet that is coupled to the restricted airflow enclosure that is provided by the dressing and that is located adjacent the wound site;

wherein the processor is configured to:

receive first sensor information from the at least one sensor system, wherein the first sensor information comprises atmospheric humidity information;

use the first sensor information comprising the atmospheric humidity information to control the power provided from the power delivery system to the oxygen concentrator in order to control an oxygen flow created by the oxygen concentrator and provided through the oxygen outlet to the restricted airflow enclosure;

receive second sensor information from the at least one sensor system; and

activate the negative pressure system to create a fluid flow from the restricted airflow enclosure and through the negative pressure outlet.

2. The system of claim 1 , wherein the second sensor information provides a blockage alarm that is indicative of a blockage in the coupling of the oxygen outlet to the restricted airflow enclosure.

3. The system of claim 2 , wherein the blockage is caused by exudate produced at the wound site and that is located in the coupling of the oxygen outlet to the restricted airflow enclosure.

4. The system of claim 3 , wherein activation of the negative pressure system to create the fluid flow from the restricted airflow enclosure and through the negative pressure outlet operates to remove the exudate that is located in the coupling of the oxygen outlet to the restricted airflow enclosure.

5. The system of claim 2 , wherein the blockage is caused by an amount of oxygen that was created by the oxygen concentrator and provided through the oxygen outlet to the restricted airflow enclosure such that a pressure in the restricted airflow enclosure exceeds a maximum pressure.

6. The system of claim 1 , wherein activation of the negative pressure system to create the fluid flow from the restricted airflow enclosure and through the negative pressure outlet operates to remove exudate produced at the wound site from the restricted airflow enclosure.

7. The system of claim 1 , wherein activation of the negative pressure system to create the fluid flow from the restricted airflow enclosure and through the negative pressure outlet operates to achieve a dressing seal when a minimum seal pressure is not maintained for a set period of time.

8. The system of claim 1 , wherein activation of the negative pressure system via a fluid saturation sensor creates the fluid flow from the restricted airflow enclosure and through the negative pressure outlet operates to remove exudate produced at the wound site from the restricted airflow enclosure.

9. The system of claim 1 , wherein activation of the negative pressure system to create the fluid flow from the restricted airflow enclosure and through the negative pressure outlet operates to maximize oxygen concentration in that restricted airflow enclosure as quickly as possible.

Assignments (2)
SECURITY INTEREST Recorded Mar 28, 2024
From: ELECTROCHEMICAL OXYGEN CONCEPTS, INC.
To: VGM GROUP INC.
Reel/Frame 066939/0307 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2022
From: NIEDERAUER, MARK Q.; DALEY, JAMES P.; MOFFETT, JOSEPH J.
To: ELECTROCHEMICAL OXYGEN CONCEPTS, INC.
Reel/Frame 058647/0565 →
Continuity (2)
Provisional Application 62833878 · Apr 15, 2019
Related Publication 20220193326A1 · Jun 23, 2022
References Cited (18)
US 8287506B2 · Wells · 2012 [cited by examiner]
US 9730838B2 · Wells · 2017 [cited by examiner]
US 10226610B2 · Wells · 2019 [cited by examiner]
US 10702686B2 · Niederauer et al. · 2020 [cited by applicant]
US 20070118096A1 · Smith et al. · 2007 [cited by applicant]
US 20150290364A1 · Wall · 2015 [cited by examiner]
US 20170165405A1 · Muser et al. · 2017 [cited by applicant]
US 20190001107A1 · Niederauer et al. · 2019 [cited by applicant]
EP 2066365A1 · 2009 [cited by applicant]
JP 2018536528T · 2018 [cited by applicant]
WO WO2008039314A2 · 2008 [cited by applicant]
WO WO2018227144A · 2018 [cited by applicant]
WO WO2018227144A1 · 2018 [cited by applicant]
WO WO2019005573A · 2019 [cited by applicant]
International Search Report and Written Opinion dated Jul. 2, 2020 issued in PCT App. No. PCT/US2020/028312 (14 pages). [cited by applicant]
Chinese office action dated Oct. 27, 2022 issued in Chinese patent application No. 202080033011.3 with English translation (12 pages). [cited by applicant]
European Supplementary Search Report dated Dec. 9, 2022 issued in European patent application No. 20792109.9 (9 pages). [cited by applicant]
Office Action dated Feb. 28, 2024 issued in related Japanese App. No. 2021-561759 (10 pages with translation). [cited by applicant]